OBJECTIVE: First-episode schizophrenia and schizoaffective patients (SZ+) show olfactory impairments, but how these relate to cognitive dysfunction remains unclear. We examined the relationship between cognitive and olfactory dysfunction in SZ+ and the clinical utility of these measures in the assessment of SZ+ patients. METHOD: First-episode SZ+ patients (n = 63) and controls (n = 63) were administered tests of odor identification and discrimination in addition to measures of manual dexterity, processing speed, attention and working memory, executive functioning, ideational fluency, and memory. We analyzed the relationships between olfactory and cognitive variables and conducted stepwise multiple regressions to identify which cognitive indices best predicted olfactory performance within the SZ+ group. Linear discriminant analysis was used to identify which measures best distinguished cases from controls. RESULTS: Among patients, odor discrimination correlated with perseverative errors and odor identification correlated with bilateral manual dexterity. Odor discrimination performance was best predicted by perseverative errors and letter fluency, whereas odor identification ability was best predicted by manual dexterity. Stepwise linear discriminant analysis revealed that manual dexterity, letter-guided word fluency, and odor discrimination best distinguished SZ+ from healthy adults. CONCLUSIONS: These findings indicate that manual dexterity, letter-guided word fluency, and odor discrimination may provide incremental information that strengthens a diagnosis of SZ+. Although odor discrimination tasks have received limited attention in schizophrenia studies, the extant data along with the present results indicate that odor discrimination tasks may have utility over odor identification measures as a neurodevelopmental risk marker. Additional studies examining odor discrimination as a predictor of SZ spectrum illness are warranted. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
OBJECTIVE: First-episode schizophrenia and schizoaffective patients (SZ+) show olfactory impairments, but how these relate to cognitive dysfunction remains unclear. We examined the relationship between cognitive and olfactory dysfunction in SZ+ and the clinical utility of these measures in the assessment of SZ+ patients. METHOD: First-episode SZ+ patients (n = 63) and controls (n = 63) were administered tests of odor identification and discrimination in addition to measures of manual dexterity, processing speed, attention and working memory, executive functioning, ideational fluency, and memory. We analyzed the relationships between olfactory and cognitive variables and conducted stepwise multiple regressions to identify which cognitive indices best predicted olfactory performance within the SZ+ group. Linear discriminant analysis was used to identify which measures best distinguished cases from controls. RESULTS: Among patients, odor discrimination correlated with perseverative errors and odor identification correlated with bilateral manual dexterity. Odor discrimination performance was best predicted by perseverative errors and letter fluency, whereas odor identification ability was best predicted by manual dexterity. Stepwise linear discriminant analysis revealed that manual dexterity, letter-guided word fluency, and odor discrimination best distinguished SZ+ from healthy adults. CONCLUSIONS: These findings indicate that manual dexterity, letter-guided word fluency, and odor discrimination may provide incremental information that strengthens a diagnosis of SZ+. Although odor discrimination tasks have received limited attention in schizophrenia studies, the extant data along with the present results indicate that odor discrimination tasks may have utility over odor identification measures as a neurodevelopmental risk marker. Additional studies examining odor discrimination as a predictor of SZ spectrum illness are warranted. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Authors: Andreia V Faria; Jeffrey Crawford; Chenfei Ye; Johnny Hsu; Anshel Kenkare; David Schretlen; Akira Sawa Journal: Schizophr Res Date: 2019-04-13 Impact factor: 4.939
Authors: Kun Yang; Luisa Longo; Zui Narita; Nicola Cascella; Frederick C Nucifora; Jennifer M Coughlin; Gerald Nestadt; Thomas W Sedlak; Marina Mihaljevic; Min Wang; Anshel Kenkare; Anisha Nagpal; Mehk Sethi; Alexandra Kelly; Pasquale Di Carlo; Vidyulata Kamath; Andreia Faria; Peter Barker; Akira Sawa Journal: Mol Psychiatry Date: 2021-10-12 Impact factor: 13.437
Authors: Andreia V Faria; Yi Zhao; Chenfei Ye; Johnny Hsu; Kun Yang; Elizabeth Cifuentes; Lei Wang; Susumu Mori; Michael Miller; Brian Caffo; Akira Sawa Journal: Hum Brain Mapp Date: 2020-12-30 Impact factor: 5.399
Authors: Hanna Jaaro-Peled; Melissa A Landek-Salgado; Nicola G Cascella; Frederick C Nucifora; Jennifer M Coughlin; Gerald Nestadt; Thomas W Sedlak; Joelle Lavoie; Sarah De Silva; Somin Lee; Katsunori Tajinda; Hideki Hiyama; Koko Ishizuka; Kun Yang; Akira Sawa Journal: Transl Psychiatry Date: 2022-03-10 Impact factor: 6.222